Personalizing septic shock treatment: Vasopressin's role under the microscope
NCT ID NCT07697144
First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time
Summary
This study looks at how the drug vasopressin affects the heart and blood flow in people with septic shock, a life-threatening condition from severe infection. Researchers want to see if different patients respond differently based on their specific heart and blood vessel status. The goal is to better understand when and how to use vasopressin for more personalized care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- vasopressin
- What this could lead to
- If successful, this could help doctors tailor vasopressin use in septic shock, potentially improving survival and recovery.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct changes in care, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK AND USE OF VASOPRESSIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH de Dieppe
Dieppe, France
-
CHU Rennes - Site Pontchaillou
Rennes, France
-
CHU d'Angers
Angers, France
-
GHE, Hôpital Louis Pradel, HCL
Lyon, France
-
GHS - Hôpital Lyon Sud, HCL
Lyon, France
-
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
-
Hôpital Hautepierre, Hôpitaux Universitaires de Strasbourg
Strasbourg, France
-
Hôpital Nord, AP-HM
Marseille, France